{"id":27994,"date":"2020-04-09T18:59:33","date_gmt":"2020-04-10T00:59:33","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=27994"},"modified":"2020-04-09T19:03:04","modified_gmt":"2020-04-10T01:03:04","slug":"animal-health-news-notes-for-april-10-2020","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 10 de abril de 2020"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas de sa\u00fade animal de 10 de abril<\/strong><strong>, 2020<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<\/p>\n<p><u>Not\u00edcias de Ganhos<\/u><\/p>\n<p>Boehringer Ingelheim<br \/>\nImmuCell Corporation<\/p>\n<p><u>Outras not\u00edcias <\/u><\/p>\n<p>Bayer<br \/>\nElanco<br \/>\nBioterap\u00eautica GeneQuine<br \/>\nMedici<br \/>\nNeogen<br \/>\nPenn Suprimentos Veterin\u00e1rios<br \/>\nAn\u00e1lise de Performance Pecu\u00e1ria<br \/>\nSu\u00ednaTech<br \/>\nVetNOW<br \/>\nZoetis (Performance Livestock Analytics)<br \/>\nZoetis (Clarifide)<br \/>\nZomedica<br \/>\n<strong>************************************<\/strong><\/p>\n<p><strong>RELEASES DE RESULTADOS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Boehringer Ingelheim <\/strong>reportou resultados para o ano inteiro de 2019. As vendas totais de Sa\u00fade Animal foram de EUR 4,03 bilh\u00f5es ($4,38 bilh\u00f5es) em 2019, um aumento de 2% em compara\u00e7\u00e3o com 2018. O faturamento nos EUA foi de EUR 1,77 bilh\u00e3o ($1,92 bilh\u00e3o), um aumento de 9% ano ap\u00f3s ano. <em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li><strong>ImmuCell Corporation<\/strong> anunciou resultados preliminares e n\u00e3o auditados de vendas de produtos para o primeiro trimestre encerrado em 31 de mar\u00e7o de 2020. As vendas totais de produtos foram de aproximadamente $4,9 milh\u00f5es, um aumento de 11% em compara\u00e7\u00e3o com o primeiro trimestre de 2019.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<\/ul>\n<p><strong>************************************<\/strong><\/p>\n<p><strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Zoetis<\/strong> anunciou a aquisi\u00e7\u00e3o de <strong>An\u00e1lise de Performance Pecu\u00e1ria<\/strong>, uma empresa de tecnologia que simplifica dados e an\u00e1lises para a ind\u00fastria pecu\u00e1ria. Os termos financeiros n\u00e3o foram divulgados. <em>(alimentos)<\/em><\/li>\n<li><strong>Zoetis<\/strong> anunciou a adi\u00e7\u00e3o de novos recursos como parte de seu teste gen\u00e9tico Clarifide Plus para bovinos. O teste agora pode ajudar a prever a lucratividade potencial da vaca durante toda a vida para o gado Holstein e Jersey, fornecendo informa\u00e7\u00f5es sobre doen\u00e7as respirat\u00f3rias e caracter\u00edsticas de fertilidade para aborto de vacas, g\u00eameos e cistos ovarianos. O Clarifide Plus tamb\u00e9m incluir\u00e1 a febre do leite entre as informa\u00e7\u00f5es dispon\u00edveis sobre o bem-estar da vaca para Holsteins, uma caracter\u00edstica anteriormente dispon\u00edvel apenas para Jerseys. <em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li><strong>Elanco<\/strong> e <strong>VetNOW<\/strong> anunciou uma colabora\u00e7\u00e3o que oferece aos veterin\u00e1rios dois meses gratuitos de acesso \u00e0 plataforma de telemedicina compat\u00edvel com VCPR da VetNOW, para que possam manter o atendimento aos animais e propriet\u00e1rios, incluindo consultas especializadas.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Sa\u00fade Animal Bayer<\/strong> anunciou que o FDA concedeu uma aprova\u00e7\u00e3o condicional para Baytril 100-CA1 (enrofloxacina) Solu\u00e7\u00e3o Injet\u00e1vel para o tratamento de anaplasmose cl\u00ednica em bovinos. O produto estar\u00e1 dispon\u00edvel para veterin\u00e1rios e pecuaristas em maio de 2020. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Corpora\u00e7\u00e3o Neogen <\/strong>anunciou que a EPA acelerou a aprova\u00e7\u00e3o de seus desinfetantes Synergize e COMPANION para combater o novo coronav\u00edrus que causa o COVID-19. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Farmac\u00eautica Zomedica <\/strong> anunciou o pre\u00e7o de sua oferta p\u00fablica anunciada anteriormente de 33.333.334 a\u00e7\u00f5es ordin\u00e1rias e warrants para comprar at\u00e9 16.666.667 a\u00e7\u00f5es ordin\u00e1rias. Os t\u00edtulos est\u00e3o sendo vendidos em uma combina\u00e7\u00e3o fixa que consiste em uma a\u00e7\u00e3o ordin\u00e1ria e 0,5 de um warrant a um pre\u00e7o de oferta p\u00fablica combinado de $0,12 por a\u00e7\u00e3o e warrant que o acompanha. Espera-se que a receita bruta seja de aproximadamente $4,0 milh\u00f5es, antes da dedu\u00e7\u00e3o de taxas e despesas. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Penn Suprimentos Veterin\u00e1rios<\/strong> anunciou uma nova parceria com <strong>Medici <\/strong>para comercializar a plataforma de telemedicina da Medici<em>. (Vantagem Veterin\u00e1ria)<\/em><\/li>\n<li><strong>Su\u00ednaTech<\/strong> anunciou que concluiu uma rodada de financiamento da S\u00e9rie A de $5 milh\u00f5es liderada pela Innova Memphis. Esses fundos ajudar\u00e3o a empresa a expandir agressivamente seus esfor\u00e7os de vendas e marketing, bem como ampliar e acelerar o desenvolvimento de produtos de sua plataforma de gerenciamento de parto.<em> (Pecuarista Nacional de Su\u00ednos)<\/em><\/li>\n<li>ALEMANHA <strong>Bioterap\u00eautica GeneQuine<\/strong> anunciou que obteve uma patente europeia para seu principal candidato \u00e0 terapia gen\u00e9tica. A patente abrange o tratamento GQ-303 para osteoartrite em humanos e seus an\u00e1logos veterin\u00e1rios GQ-302 e GQ-301 em c\u00e3es e cavalos, respectivamente. <em>(Farm\u00e1cia Animal)<\/em><\/li>\n<\/ul>\n<p>***********************************<br \/>\n<strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-27995\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\" alt=\"\" width=\"843\" height=\"640\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg 843w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10-480x364.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 843px, 100vw\" \/><\/strong>***********************************<br \/>\n<strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n<\/strong><\/p>\n<ul>\n<li>EUA \u2013 ORIENTA\u00c7\u00c3O DA FDA \u2013 A FDA est\u00e1 ciente de que a pandemia de COVID-19 pode ter um impacto nos estudos em andamento que est\u00e3o sendo conduzidos para apoiar o desenvolvimento de novos medicamentos para animais. Para ajudar a minimizar o impacto potencial da pandemia de COVID-19 no desenvolvimento de novos medicamentos para animais, o FDA emitiu orienta\u00e7\u00f5es com recomenda\u00e7\u00f5es para patrocinadores que conduzem estudos em andamento para apoiar o desenvolvimento de novos medicamentos para animais. Para mais informa\u00e7\u00f5es, clique <a href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-270-guidance-conduct-and-review-studies-support-new-animal-drug-development-during-covid-19?utm_campaign=4-3-2020-GFI270&amp;utm_medium=email&amp;utm_source=Eloqua\">aqui.<\/a>\u00a0<em><em>(FDA)<\/em><\/em><\/li>\n<li>AUSTR\u00c1LIA \u2013 COVID-19 Um novo relat\u00f3rio de pesquisa da Monash University, na Austr\u00e1lia, descobriu que uma \u00fanica dose de ivermectina pode interromper o crescimento do SARS-CoV-2 em cultura de c\u00e9lulas, erradicando efetivamente todo o material gen\u00e9tico do v\u00edrus em dois dias. A ivermectina \u00e9 aprovada para uso em humanos e animais como um antiparasiticida de amplo espectro. A pesquisa foi publicada em <em>Pesquisa antiviral<\/em>. Para ler o jornal, clique <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0166354220302011\">aqui.<\/a> <em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li>EUA \u2013 COVID-19 O USDA confirmou a presen\u00e7a do SARS-CoV-2, o v\u00edrus que causa o COVID-19, em um tigre no Zool\u00f3gico do Bronx, em Nova York, que apresentava sinais cl\u00ednicos de doen\u00e7a respirat\u00f3ria. Acredita-se que o animal tenha contra\u00eddo a doen\u00e7a de um funcion\u00e1rio do zool\u00f3gico que estava transmitindo ativamente o v\u00edrus. N\u00e3o houve relatos de animais de estima\u00e7\u00e3o ou gado adoecendo com COVID-19 nos EUA, e apenas quatro casos relatados no mundo de c\u00e3es e gatos com teste positivo para o v\u00edrus. Neste momento, n\u00e3o h\u00e1 evid\u00eancias de que animais dom\u00e9sticos, incluindo animais de estima\u00e7\u00e3o e gado, possam transmitir o COVID-19 para as pessoas. No entanto, a AVMA reafirmou sua recomenda\u00e7\u00e3o de que, por \u201cmuita cautela\u201d, os infectados com COVID-19 devem restringir o contato com animais, assim como fariam com humanos, at\u00e9 que se saiba mais sobre o v\u00edrus.<em>(Not\u00edcias da Pr\u00e1tica Veterin\u00e1ria)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><\/p>\n<p>Quando amea\u00e7ados por uma variedade de est\u00edmulos, os humanos procuram garantir um suprimento adequado, ou frequentemente mais do que adequado, de alimentos e outros itens considerados necess\u00e1rios. \u00c9 observado em mudan\u00e7as clim\u00e1ticas r\u00e1pidas quando os carrinhos de supermercado pr\u00e9-tempestade est\u00e3o transbordando. Agora sabemos que tamb\u00e9m faz parte do comportamento pand\u00eamico. Talvez seja uma parte do instinto de sobreviv\u00eancia que manteve a esp\u00e9cie viva e nos impede de ficar sem ela.<\/p>\n<p>Infelizmente, na semana passada, v\u00e1rios relatos de um n\u00famero significativo de casos de COVID-19 entre trabalhadores da ind\u00fastria de processamento de carne resultaram no fechamento e na desacelera\u00e7\u00e3o de algumas f\u00e1bricas. Embora certamente n\u00e3o seja um ponto de inflex\u00e3o, \u00e9 um lembrete de que a cadeia alimentar \u00e9 vulner\u00e1vel e que os casos de COVID-19 n\u00e3o se limitam \u00e0s \u00e1reas urbanas.<\/p>\n<p>Estamos passando por um per\u00edodo no tempo em que desenvolvemos uma maior aprecia\u00e7\u00e3o de muitas coisas consideradas \u00f3bvias no passado. \u00c9 um lembrete para tirarmos o chap\u00e9u a todos os que est\u00e3o na cadeia de abastecimento de alimentos, muitos dos quais s\u00e3o clientes de sa\u00fade animal, que por sua pr\u00f3pria conta e risco est\u00e3o nos mantendo alimentados enquanto nos abrigamos.<\/p>\n<p><em>Cary Christensen<br \/>\n<\/em><\/p>\n<p>***********************************<\/p>\n<p><strong>SUA VIS\u00c3O<br \/>\n<\/strong><\/p>\n<p><span id=\"x_email_112\"><span id=\"x_email_113\">Torna-se mais real quando afeta algu\u00e9m pr\u00f3ximo a voc\u00ea. Na semana passada, perguntamos: voc\u00ea ou algu\u00e9m que voc\u00ea conhece pelo primeiro nome - fam\u00edlia, amigo, parceiro de neg\u00f3cios - foi diagnosticado com COVID-19? Trinta e cinco por cento dos entrevistados disseram que sim, algu\u00e9m que eles conheciam foi diagnosticado com COVID-19.<\/span><\/span><\/p>\n<p><span id=\"x_email_114\"><span id=\"x_email_115\">A pandemia \u00e9 uma mudan\u00e7a acelerada na forma como obtemos muitos dos produtos que usamos em nossas casas. Pergunta desta semana:<\/span><\/span><\/p>\n<p><span id=\"x_email_117\"><span id=\"x_email_118\"><span id=\"x_email_119\"><a id=\"x_auto_assign_link_num_9\" href=\"http:\/\/trk.cp20.com\/click\/g9hw-18hc-79af-d6tjd4\/\" target=\"_blank\" rel=\"noopener noreferrer\" name=\"x_https surveymonkey r 8QZWV8P 2\" data-auth=\"NotApplicable\">Voc\u00ea come\u00e7ou a fazer compras online e receber mantimentos em casa desde o in\u00edcio da pandemia?<\/a><\/span><\/span><\/span><\/p>\n<p><strong>\u00a0<\/strong>**********************************<\/p>\n<p>Problemas para visualizar esta newsletter? Voc\u00ea pode visualiz\u00e1-lo online em <a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a><\/p>\n<p><em>Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting.<\/em><\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<\/p>\n<p>Brakke Consultoria<br \/>\nRua Green Valley, 806<br \/>\nSu\u00edte 200<br \/>\nGreensboro, NC 27408<\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 10 de abril de 2020 Copyright \u00a9 Brakke Editora Consultora: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias sobre ganhos Boehringer Ingelheim ImmuCell Corporation Outras not\u00edcias Bayer Elanco GeneQuine Biotherapeutics Medici Neogen Penn Veterinary Supply Performance Livestock Analytics SwineTech VetNOW Zoetis (Performance Livestock Analytics) Zoetis (Clarifide) Zomedica ******************** **************** DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA A Boehringer Ingelheim relatou resultados para todo o ano de 2019. As vendas totais de Sa\u00fade Animal foram de 4,03 bilh\u00f5es de euros ($4,38 bilh\u00f5es) em 2019, um aumento de 2% em compara\u00e7\u00e3o com 2018. O volume de neg\u00f3cios nos EUA foi de 1,77 mil milh\u00f5es de euros ($1,92 mil milh\u00f5es), um aumento de 9% ano ap\u00f3s ano. (Animal Pharm) ImmuCell Corporation anunciou resultados preliminares e n\u00e3o auditados de vendas de produtos para o primeiro trimestre encerrado em 31 de mar\u00e7o de 2020. As vendas totais de produtos foram de aproximadamente $4,9 milh\u00f5es, um aumento de 11% em compara\u00e7\u00e3o com o primeiro trimestre de 2019. (comunicado \u00e0 imprensa da empresa) ************************************ COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA Zoetis anunciou a aquisi\u00e7\u00e3o da Performance Livestock Analytics, uma tecnologia empresa que simplifica dados e an\u00e1lises para a ind\u00fastria pecu\u00e1ria. Os termos financeiros n\u00e3o foram divulgados. (Alimentos) Zoetis anunciou a adi\u00e7\u00e3o de novos recursos como parte de seu teste gen\u00e9tico Clarifide Plus para bovinos. O teste agora pode ajudar a prever a rentabilidade potencial da vida das vacas para o gado Holand\u00eas e Jersey, fornecendo informa\u00e7\u00f5es sobre doen\u00e7as respirat\u00f3rias e caracter\u00edsticas de fertilidade para aborto de vacas, gemelaridades e cistos ovarianos. Clarifide Plus tamb\u00e9m ir\u00e1<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-27994","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for April 10, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Earnings News Boehringer Ingelheim ImmuCell Corporation Other News Bayer Elanco GeneQuine Biotherapeutics Medici Neogen Penn Veterinary Supply Performance Livestock Analytics SwineTech VetNOW Zoetis (Performance Livestock Analytics) Zoetis (Clarifide) Zomedica ************************************ COMPANY EARNINGS RELEASES Boehringer Ingelheim reported results for the full year 2019. Total Animal Health sales were EUR 4.03 billion ($4.38 billion) in 2019, an increase of 2% compared to 2018. US turnover was EUR 1.77 billion ($1.92 billion), an increase of 9% year-over-year. (Animal Pharm) ImmuCell Corporation announced preliminary, unaudited product sales results for the first quarter ended March 31, 2020. Total product sales were approximately $4.9 million, an increase of 11% compared to the first quarter of 2019. (company press release) ************************************ COMPANY NEWS RELEASES Zoetis announced the acquisition of Performance Livestock Analytics, a technology company that simplifies data and analytics for the livestock industry. Financial terms were not disclosed. (Feedstuffs) Zoetis announced the addition of new capabilities as part of its Clarifide Plus genetics test for cattle. The test can now help predict potential cow lifetime profitability for Holstein and Jersey cattle by providing insight into respiratory disease and fertility traits for cow abortion, twinning and ovarian cysts. Clarifide Plus will alsoView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-10T00:59:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-10T01:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for April 10, 2020\",\"datePublished\":\"2020-04-10T00:59:33+00:00\",\"dateModified\":\"2020-04-10T01:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/\"},\"wordCount\":1134,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\",\"datePublished\":\"2020-04-10T00:59:33+00:00\",\"dateModified\":\"2020-04-10T01:03:04+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for April 10, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for April 10, 2020 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Earnings News Boehringer Ingelheim ImmuCell Corporation Other News Bayer Elanco GeneQuine Biotherapeutics Medici Neogen Penn Veterinary Supply Performance Livestock Analytics SwineTech VetNOW Zoetis (Performance Livestock Analytics) Zoetis (Clarifide) Zomedica ************************************ COMPANY EARNINGS RELEASES Boehringer Ingelheim reported results for the full year 2019. Total Animal Health sales were EUR 4.03 billion ($4.38 billion) in 2019, an increase of 2% compared to 2018. US turnover was EUR 1.77 billion ($1.92 billion), an increase of 9% year-over-year. (Animal Pharm) ImmuCell Corporation announced preliminary, unaudited product sales results for the first quarter ended March 31, 2020. Total product sales were approximately $4.9 million, an increase of 11% compared to the first quarter of 2019. (company press release) ************************************ COMPANY NEWS RELEASES Zoetis announced the acquisition of Performance Livestock Analytics, a technology company that simplifies data and analytics for the livestock industry. Financial terms were not disclosed. (Feedstuffs) Zoetis announced the addition of new capabilities as part of its Clarifide Plus genetics test for cattle. The test can now help predict potential cow lifetime profitability for Holstein and Jersey cattle by providing insight into respiratory disease and fertility traits for cow abortion, twinning and ovarian cysts. Clarifide Plus will alsoView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-april-10-2020\/","og_site_name":"Brakke Consulting Website","article_published_time":"2020-04-10T00:59:33+00:00","article_modified_time":"2020-04-10T01:03:04+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg","type":"","width":"","height":""}],"author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for April 10, 2020","datePublished":"2020-04-10T00:59:33+00:00","dateModified":"2020-04-10T01:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/"},"wordCount":1134,"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/","url":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg","datePublished":"2020-04-10T00:59:33+00:00","dateModified":"2020-04-10T01:03:04+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2020\/04\/Stock-Table-4.10.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/animal-health-news-notes-for-april-10-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for April 10, 2020"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=27994"}],"version-history":[{"count":5,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27994\/revisions"}],"predecessor-version":[{"id":27998,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/27994\/revisions\/27998"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=27994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=27994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=27994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}